.svg){kind=icon}
Cannabis products applied to the skin are often grouped together under the word “topicals.” However, a topical lotion and a transdermal patch are not necessarily designed to work in the same way.
Traditional cannabis topicals are generally intended for application to a specific area of the skin. Patients may choose them when they want a localized, non-inhaled product that can be incorporated into a daily routine.
Transdermal products are formulated with a different goal. They are designed to move cannabinoids through the skin barrier so they can reach systemic circulation and potentially produce effects beyond the application area.
Understanding this distinction can help Florida medical cannabis patients set more realistic expectations, interpret product labels, and avoid assuming that every cannabis product placed on the skin will produce the same experience.
What Is a Cannabis Topical?
A cannabis topical is a lotion, cream, balm, gel, salve, or similar product applied directly to the outside of the skin.
Topicals are commonly marketed for localized application. A patient may apply the product to a particular joint, muscle group, or other external area rather than consuming cannabis through inhalation or digestion.
The skin contains components of the endocannabinoid system, including cannabinoid receptors and signaling pathways involved in sensation, inflammation, and skin function. This has led researchers to study whether cannabinoids applied to the skin may influence activity near the application area.
However, cannabis research on topical effectiveness remains limited. Product ingredients, cannabinoid concentration, skin condition, application amount, and formulation can all affect the experience.
A topical should not be assumed to treat the underlying cause of pain, inflammation, arthritis, skin disease, or another medical condition.
What Is a Transdermal Cannabis Product?
A transdermal cannabis product is specifically designed to move cannabinoids across the skin barrier and into circulation.
Common pharmaceutical transdermal products include certain nicotine, hormone, and motion-sickness patches. These systems use carefully developed formulations to release active ingredients at a controlled rate.
Cannabis transdermal products may come in the form of patches, gels, or specialized creams. They may contain penetration-enhancing ingredients intended to help cannabinoids cross the outer layer of the skin.
Because the goal is systemic delivery, a true transdermal THC product may have a greater possibility of producing whole-body effects, including intoxication or impairment.
The words “cream,” “gel,” or “lotion” do not confirm that a product is transdermal. The package should specifically identify its intended administration route.
The Skin Barrier Matters
The outer layer of the skin, known as the stratum corneum, is designed to keep outside substances from entering the body easily.
This protective barrier is one reason applying a cannabinoid to the skin does not automatically mean that a substantial amount will enter the bloodstream.
Cannabinoids are highly lipophilic, meaning they are attracted to fats and oils. Although this can help them interact with the skin’s lipid-rich layers, their molecular characteristics can make consistent transdermal delivery challenging.
Manufacturers may use carriers, emulsifiers, encapsulation systems, penetration enhancers, or specially designed adhesives to improve delivery.
A conventional lotion that remains primarily within the upper skin layers should not be treated as equivalent to a pharmaceutical-style transdermal system.
Localized Effects vs. Systemic Effects
The main practical difference is where the formulation is intended to work.
A standard topical is generally selected for localized application. It may not produce the noticeable intoxication associated with inhaled or swallowed THC, particularly when used as directed on intact skin.
A transdermal product is designed for broader absorption. Depending on the cannabinoid content and dose, systemic effects may be possible.
Patients should never assume that a skin-applied product cannot impair them. Read the label, begin with a small amount, and allow time to evaluate the response before driving or performing safety-sensitive activities.
How Quickly Do Skin-Applied Products Work?
Onset varies considerably.
A topical may begin feeling noticeable relatively soon after application, especially when the formula contains cooling, warming, or aromatic ingredients. Those immediate sensations may come from ingredients such as menthol or botanical oils rather than cannabinoids alone.
Transdermal products may release cannabinoids gradually over several hours. A patch may be designed for extended delivery rather than rapid onset.
Timing can depend on:
- Product formulation
- Amount applied
- Application area
- Skin thickness
- Skin temperature
- Blood flow
- Whether the skin is covered
- Individual sensitivity
- Cannabinoid concentration
Patients should follow the specific package directions rather than applying more because an immediate effect is not noticeable.
Application and Safety Considerations
Topical and transdermal products should generally be applied only to clean, dry, intact skin unless the manufacturer or physician instructs otherwise.
Avoid applying cannabis products to:
- Open cuts or wounds
- Irritated or infected skin
- The eyes or mouth
- Sensitive mucous membranes
- Areas affected by an unexplained rash
Wash your hands after application unless the hands are the intended treatment area.
Do not use a heating pad over the product unless the instructions specifically permit it. Heat may change skin absorption and could increase systemic exposure from certain transdermal formulations.
Occlusive bandages and tight wraps may also change absorption. A lotion should not be covered simply to make it “work better.”
Patients with sensitive skin may want to test a small amount first. Discontinue use if significant redness, swelling, burning, blistering, or other irritation occurs.
Can Topical THC Cause a Positive Drug Test?
Patients should not assume that skin-applied cannabis can never affect drug testing.
A standard topical intended for localized use may be less likely to create significant systemic THC exposure than inhaled, oral, or transdermal cannabis. However, formulations differ, labels may be incomplete, and contamination can occur.
A true transdermal THC product is intended to cross into circulation and may create a greater risk of detectable metabolites.
Anyone subject to workplace, legal, athletic, or medical drug testing should discuss the risk with the appropriate program administrator. No cannabis product should be described as guaranteed drug-test safe.
Cannabis Terpenes in Topical Products
Cannabis terpenes contribute aroma and may be included in lotions, balms, and gels. Frequently discussed terpenes include limonene, linalool, pinene, myrcene, humulene, and beta-caryophyllene.
Terpenes should not be confused with proven medical ingredients. Their presence does not confirm that a product will penetrate the skin more effectively or produce a specific therapeutic result.
Some aromatic compounds may also irritate sensitive skin. Patients should review the full ingredient list, especially if they have allergies or a history of reactions to fragrances or botanical oils.
Green Dragon Florida Products and Route Comparisons
Green Dragon’s current Florida menu has a limited topical selection and does not clearly identify an available transdermal cannabis patch. The following products help illustrate the difference between localized topical application and systemic oral administration.
The tablets and chews are not substitutes for a topical or transdermal product.
Le Remedie Extra Strength THC Pain Relief Lotion — Largo
Le Remedie Extra Strength THC Pain Relief Lotion is a skin-applied product containing 450 mg of total THC. The formula includes jojoba oil, avocado oil, and shea butter.
This is presented as a topical lotion rather than a confirmed transdermal system. Patients should apply it incrementally according to the physical package and physician guidance.
Le Remedie Fast-Acting THC Tablets — Inverness
Le Remedie Fast-Acting THC Tablets contain 100 mg of total THC, divided into ten orally administered tablets.
Unlike a standard topical, an oral tablet is intended to create systemic cannabinoid exposure. It should not be used as a milligram-for-milligram comparison with a lotion.
Raspberry Bliss Indica Chews — Boynton Beach West
Raspberry Bliss Indica Chews provide another systemic oral format containing 100 mg of total THC per package.
Swallowed THC passes through digestion and liver metabolism, creating a different onset, duration, and impairment profile from a skin-applied topical.
Availability and laboratory results may vary by Green Dragon Florida location.
The Green Dragon Takeaway
Topical and transdermal cannabis products should not be treated as interchangeable.
A conventional topical is generally intended for localized external application. A transdermal product is specially formulated to move cannabinoids through the skin and into systemic circulation.
Check the route printed on the package, apply only as instructed, avoid damaged skin, and do not assume that a skin-applied product is incapable of causing impairment.
When a clearly labeled transdermal product is not available, an oral or inhaled product should not be presented as a direct substitute. Each route has its own onset, duration, dosing, and safety considerations.